Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
9.58
+0.15 (1.59%)
At close: May 12, 2025, 4:00 PM
9.90
+0.32 (3.34%)
After-hours: May 12, 2025, 6:33 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $127.16 million as of May 12, 2025. Its market cap has decreased by -21.76% in one year.
Market Cap
127.16M
Enterprise Value
123.07M
1-Year Change
-21.76%
Ranking
Category
Stock Price
$9.58
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $127.16M, an increase of 85.13%. That is a compound annual growth rate of 14.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 125.17M | -15.21% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.30B |
| Johnson & Johnson | 370.87B |
| UnitedHealth Group | 343.58B |
| AbbVie | 335.74B |
| Novo Nordisk | 292.03B |
| Abbott Laboratories | 229.64B |
| Novartis AG | 213.30B |
| AstraZeneca | 210.42B |